1.42
Schlusskurs vom Vortag:
$1.46
Offen:
$1.45
24-Stunden-Volumen:
49,064
Relative Volume:
0.09
Marktkapitalisierung:
$200.80M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-12.88%
1M Leistung:
-27.18%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
Veraxa Biotech Ag Stock (VRXA) Company Profile
Firmenname
Veraxa Biotech Ag
Sektor
Branche
Telefon
-
Adresse
-
Compare VRXA vs VRTX, REGN, MRNA, ARGX, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
VRXA
Veraxa Biotech Ag
|
1.42 | 233.32M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
510.72 | 130.64B | 12.34B | 4.34B | 3.71B | 16.87 |
|
REGN
Regeneron Pharmaceuticals Inc
|
798.17 | 80.46B | 14.92B | 4.42B | 3.79B | 41.04 |
|
MRNA
Moderna Inc
|
172.94 | 57.48B | 2.23B | -3.19B | -1.60B | -8.1462 |
|
ARGX
Argen X Se Adr
|
988.20 | 61.58B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
365.67 | 39.20B | 5.76B | 514.49M | 1.10B | 4.4813 |
Veraxa Biotech Ag Aktie (VRXA) Neueste Nachrichten
Veraxa Biotech (VRXA) Insider Trading Activity 2026 - marketbeat.com
Veraxa Biotech AG Stock Price: VRXA Stock Chart, Market Cap & News Today - CoinGecko
VERAXA Biotech Appoints Dr. Christoph Erkel as CSO to Steer BiTAC® Toward Clinical Trials - citybuzz -
Veraxa Biotech (VRXA) Stock Price, News & Analysis - Stock Titan
VERAXA Biotech Designates Raju Willener as CFO - Yahoo Finance
VERAXA Biotech (NASDAQ: VRXA) Appoints Raju Willener As Chief Financial Officer - Menafn
Veraxa Biotech AG (NASDAQ: VRXA) Names Raju Willener as CFO Following De-SPAC Completion - Kalkine Media
symbol__ Stock Quote Price and Forecast - CNN
VERAXA Biotech (VRXA) Appoints Raju Willener as Chief Financial Officer - Yahoo Finance
VERAXA Biotech (NASDAQ: VRXA) Appoints Raju Willener as Chief Financial Officer - TradingView
VRXA Rises As Veraxa Biotech AG Draws Trader Focus - timothysykes.com
Veraxa Biotech AG Company Profile & Introduction - Moomoo
VRXA Jumps As Traders Focus On Biotech Breakout Setup - timothysykes.com
VRXA Should I Buy - Intellectia AI
VERAXA Biotech Appoints Veteran Finance Executive Raju Willener as CFO to Drive Capital Strategy and Oncology Pipeline Growth - citybuzz -
Veraxa Biotech AG (VRXA) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Veraxa Biotech names Raju Willener as chief financial officer By Investing.com - Investing.com Australia
Veraxa Biotech AG Announces Chief Financial Officer Changes - marketscreener.com
Veraxa Biotech stock rises after naming Raju Willener as CFO By Investing.com - Investing.com India
Veraxa Biotech stock rises after naming Raju Willener as CFO - investing.com
Finance veteran behind CHF 30B portfolios joins Veraxa Biotech (VRXA) as CFO - Stock Titan
Veraxa Biotech names Raju Willener as chief financial officer - Investing.com
VERAXA Biotech Appoints Raju Willener as Chief Financial Officer - kommunikasjon.ntb.no
Veraxa Biotech (VRXA) 10K Form and Latest SEC Filings 2026 - MarketBeat
Insider Buys Additional CHF75k In Veraxa Biotech Stock - simplywall.st
Veraxa Biotech (VRXA) Stock Chart and Price History 2026 - marketbeat.com
Finanzdaten der Veraxa Biotech Ag-Aktie (VRXA)
Es liegen keine Finanzdaten für Veraxa Biotech Ag (VRXA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Veraxa Biotech Ag-Aktie (VRXA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Antz Christoph Rudiger | Chief Executive Officer |
Aug 27 '26 |
Buy |
1.53 |
5,000 |
7,650 |
5,000 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):